Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Engels

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Molecular Oncology|December 27, 2015
The clinical prognostic value of molecular intrinsic tumor subtypes in older breast cancer patients: A FOCUS study analysisCharla C Engels, Mandy Kiderlen, Esther Bastiaannet, et al.
Molecular Oncology|December 27, 2015
The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysisCharla C Engels, Nienke A de Glas, Anita Sajet, et al.
Breast Cancer Research and Treatment|November 8, 2013
Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patientsEsther M de Kruijf, Charla C Engels, Willemien van de Water, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2013
Diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysisM Kiderlen, N A de Glas, E Bastiaannet, et al.
Circulation Research|May 15, 2012
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5Jenny X Chen, Markus Krane, Marcus-Andre Deutsch, et al.
Breast Cancer Research and Treatment|February 14, 2015
Contralateral breast cancer risk in relation to tumor morphology and age-in which patients is preoperative MRI justified?N A de Glas, C C Engels, E Bastiaannet, et al.
Cardiovascular Research|August 2, 2014
Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytesBrian O Bingen, Marc C Engels, Martin J Schalij, et al.
Breast Cancer Research and Treatment|December 24, 2017
Prognostic value of tumor-stroma ratio combined with the immune status of tumors in invasive breast carcinomaK M H Vangangelt, G W van Pelt, C C Engels, et al.
British Journal of Cancer|June 18, 2014
Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinomaC C Engels, D B Y Fontein, P J K Kuppen, et al.
Breast Cancer Research and Treatment|November 7, 2013
The prognostic value of apoptotic and proliferative markers in breast cancerCharla C Engels, Francesca Ruberta, Esther M de Kruijf, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Molecular Oncology|December 27, 2015
The clinical prognostic value of molecular intrinsic tumor subtypes in older breast cancer patients: A FOCUS study analysisCharla C Engels, Mandy Kiderlen, Esther Bastiaannet, et al.
Molecular Oncology|December 27, 2015
The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysisCharla C Engels, Nienke A de Glas, Anita Sajet, et al.
Breast Cancer Research and Treatment|November 8, 2013
Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patientsEsther M de Kruijf, Charla C Engels, Willemien van de Water, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2013
Diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysisM Kiderlen, N A de Glas, E Bastiaannet, et al.
Circulation Research|May 15, 2012
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5Jenny X Chen, Markus Krane, Marcus-Andre Deutsch, et al.
Breast Cancer Research and Treatment|February 14, 2015
Contralateral breast cancer risk in relation to tumor morphology and age-in which patients is preoperative MRI justified?N A de Glas, C C Engels, E Bastiaannet, et al.
Cardiovascular Research|August 2, 2014
Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytesBrian O Bingen, Marc C Engels, Martin J Schalij, et al.
Breast Cancer Research and Treatment|December 24, 2017
Prognostic value of tumor-stroma ratio combined with the immune status of tumors in invasive breast carcinomaK M H Vangangelt, G W van Pelt, C C Engels, et al.
British Journal of Cancer|June 18, 2014
Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinomaC C Engels, D B Y Fontein, P J K Kuppen, et al.
Breast Cancer Research and Treatment|November 7, 2013
The prognostic value of apoptotic and proliferative markers in breast cancerCharla C Engels, Francesca Ruberta, Esther M de Kruijf, et al.
Pageof 11